-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Tenax Therapeutics, Raises Price Target to $25

Benzinga·12/17/2025 12:57:00
Listen to the news
Guggenheim analyst Seamus Fernandez maintains Tenax Therapeutics (NASDAQ:TENX) with a Buy and raises the price target from $14 to $25.